We scan new podcasts and send you the top 5 insights daily.
Unlike categories measuring recurring purchases or constant digital touchpoints, healthcare members avoid interacting until they face a crisis or vulnerability. Because repeated engagement is undesirable for consumers, healthcare KPIs must center on getting rare interactions right and leveraging earned trust as a strategic growth and retention asset.
Marketers often struggle to find a direct ROI for trust-building activities. The reality is there is no simple framework. Trust is the foundation for any B2B relationship; without it, no commercial success is possible. Therefore, metrics like revenue, renewals, and customer growth are the most direct indicators of trust.
To gain credibility with leadership and sales, marketers should stop hiding behind large vanity metrics like "millions of impressions." Instead, focus on small, directly attributable numbers that clearly demonstrate business impact. Honesty with smaller, meaningful data builds more trust.
To evaluate AI's role in building relationships, marketers must look beyond transactional KPIs. Leading indicators of success include sustained engagement, customers volunteering more information, and recommending the experience to others. These metrics quantify brand trust and empathy—proving the brand is earning belief, not just attention.
Metrics like high Net Promoter Scores fail to capture genuine human connection in digital interactions. Instead of chasing vanity KPIs, pharma should seek the "digital equivalent of a smile"—behavioral signals that indicate a truly positive and human customer experience.
Instead of focusing only on transactional frequency, brands should measure how quickly a customer re-engages after a documented error. This metric reveals the strength of their emotional loyalty and trust, separating them from purely habitual or transactional customers.
In an age of automated, omnichannel engagement, vanity metrics like open and click rates are insufficient. CMOs must elevate customer lifetime value (CLV) as the primary success metric, shifting focus to measuring the long-term strength of customer relationships over single-interaction performance.
For B2B newsletters focused on building trust, the primary success metric should be reply rates, not opens or clicks. Getting direct replies is a powerful signal that content is resonating deeply, as readers are conditioned not to reply to brand emails. This qualitative feedback is more valuable for measuring trust than passive clicks.
Open and click rates are ineffective for measuring AI-driven, two-way conversations. Instead, leaders should adopt new KPIs: outcome metrics (e.g., meetings booked), conversational quality (tracking an agent's 'I don't know' rate to measure trust), and, ultimately, customer lifetime value.
Instead of focusing solely on quarterly revenue, a successful rare disease launch was measured by KPIs like the number of patients identified and the speed of early intervention. These patient-focused metrics served as leading indicators that ultimately translated into commercial success and a stronger external narrative.
Midi initially focused its trust-building efforts almost entirely on the clinician visit itself, only to realize that trust degrades if onboarding, lab reminders, and referral follow-ups are neglected. Relying on individual clinician charisma also introduces platform risk if providers depart. Digital health companies must purposefully embed operational reliability and communication into the brand experience outside the consultation room.